Evidence-based insights for the pharmaceutical industry

With Inpharmation you gain access to decades of experience in delivering solutions that have been extensively validated for use in the pharmaceutical industry. All our approaches are designed to maximize your forecast accuracy, with deliverables that fit flexibly with your specific project requirements.
Reduction in pricing errors compared to traditional pricing methodologies.
Countries tracked in international reference pricing regulation database.
Reduction in peak demand forecasting error compared to simplistic approaches.
Reduction in relative forecast error provided by Inpharmation’s Pharma-Specific Conjoint versus choice-based conjoint.

Pharmaceutical executive training courses

Inpharmation’s Chairman, Gary Johnson, delivers Europe’s leading pharmaceutical forecasting and pricing executive training courses.
Find out more about our Pricing and Market Access Training and Forecasting Training.

"Europe's most respected pharma forecasting & pricing specialist consultancy."

Centre for Executive Leadership


Pharma-Specific Conjoint

Evidence-based conjoint analysis for an evidence-based industry

By Gary Johnson

Value Pricing for Market Access

Evidence-based pricing for pharmaceuticals

By Gary Johnson

Sales Forecasting for Pharmaceuticals

An evidence-based approach

By Gary Johnson

Request one of our book chapters

By clicking on the “Submit Request” button you are providing consent for us to store your data and contact you. You may withdraw your consent at any time by instructing us at .

View our Privacy Policy for more information.

Please note that Inpharmation literature and case study materials constitute Inpharmation intellectual property and are intended for the pharmaceutical industry. Inpharmation is under no obligation to distribute these materials to non-pharmaceutical industry employees or competitors.

Scroll Top